Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kaynoosh Homayouni, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01680263
First received: July 13, 2012
Last updated: September 3, 2012
Last verified: September 2012

July 13, 2012
September 3, 2012
February 2012
June 2012   (final data collection date for primary outcome measure)
Pain (VAS)and swelling scores [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]
Visual analog scale for pain evaluation Assessment of the local swelling via palpation
Same as current
Complete list of historical versions of study NCT01680263 on ClinicalTrials.gov Archive Site
The number of participants with adverse events [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]
The number of participants with adverse events
Same as current
Not Provided
Not Provided
 
Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis
Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.

The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Pes Anserinus Tendinobursitis
  • Device: Kinesiotaping
    Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval
    Other Name: taping
  • Procedure: NSAIDs/Physical therapy
    Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.
    Other Names:
    • non-steroidal anti-inflammatory drugs
    • physical therapy
  • Experimental: Kinesiotaping
    Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1 week interval
    Intervention: Device: Kinesiotaping
  • Active Comparator: NSAIDs/Physical therapy
    treatment was done with NSAIDs and 10 sessions of daily physical therapy.
    Intervention: Procedure: NSAIDs/Physical therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
46
July 2012
June 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with clinical diagnosis of pes anserinus tendino-bursitis.

Exclusion Criteria:

  • Previous history of trauma or surgery on the knee joint,
  • History of NSAIDs induced acid-peptic disease
  • Systemic and rheumatic diseases
Both
20 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
NCT01680263
K Homayouni
No
Kaynoosh Homayouni, Shiraz University of Medical Sciences
Shiraz University of Medical Sciences
Not Provided
Study Chair: Kaynoosh Homayouni, M.D. Shiraz University of Medical Sciences
Principal Investigator: Shima Foruzi, M.D. Shiraz University of Medical Sciences
Principal Investigator: Fereshte Kalhori, M.D. Shiraz University of Medical Sciences
Shiraz University of Medical Sciences
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP